重症监护医学
生活质量(医疗保健)
疾病
哮喘
人口
气道
吸入性皮质类固醇
医学
麻醉
环境卫生
内科学
护理部
作者
Darko Stojkov,Shída Yousefi,Hans‐Uwe Simon
标识
DOI:10.1016/j.jaci.2023.09.031
摘要
Asthma is a chronic airway disease affecting more than 4.5% of the global population; it contributes to more than half a million deaths annually. Thus far, there is no cure for asthma, although treatments are available to manage its symptoms and improve the quality of life of affected patients. Inhaled corticosteroids (CSs), together with long-acting bronchodilators, are the most effective long-term medications currently used for the treatment of asthma, yet not all patients respond to CSs owing to the fact that, at least partially, asthma is a highly heterogenous disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI